Gefitinib is a medication used to treat certain types of lung cancer, specifically non-small cell lung cancer that has specific genetic changes called EGFR mutations. It helps slow down the growth of cancer cells in the lungs and can be prescribed when other treatments haven't been effective.
Treatment Of Locally Advanced Or Metastatic Non-small Cell Lung Cancer With Activating Mutations Of Epidermal Growth Factor Receptor: